Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 01 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 97.88 and Closed at: 94.92, which is -4.89% of previous session's close. It moved within a range of 93.50 and 98.50
The session was a Bearish session with an average volume of 817000, which is 26.84% of previous session's volumes.
- There is some negative change in the short term trend, but its too soon to jump onto conclusions.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 2 days back on short term averages
A Dead cross was found 5 days back on mid term averages
Support for tomorrow is 91.71 and resistance for tomorrow is 96.71
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 92.78, 90.64 resistance for tomorrow's hourly charts is 97.78, 100.64
10 Day SMA for Protagonist Therapeutics (PTGX) is 99.83 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 100.93 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 101.59 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 94.19 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 84.58 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 100.93 and 200 DMA is at 84.58, while 50 DMA and 100 DMA are at 101.59 and 94.19 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 100.93 and 20 EMA is at 100.38
| Date | Closing Price | 20 SMA | 20 EMA |
| 01 Mon Jun | 94.92 | 100.93 | 100.38 |
| 29 Fri May | 99.56 | 101.16 | 100.95 |
| 28 Thu May | 100.41 | 101.11 | 101.1 |
| 27 Wed May | 102.21 | 101.03 | 101.17 |
| 26 Tue May | 99.98 | 100.85 | 101.06 |
| 22 Fri May | 99.19 | 100.91 | 101.17 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 101.59 and 50 EMA is at 99.47
| Date | Closing Price | 50 SMA | 50 EMA |
| 01 Mon Jun | 94.92 | 101.59 | 99.47 |
| 29 Fri May | 99.56 | 101.67 | 99.66 |
| 28 Thu May | 100.41 | 101.71 | 99.66 |
| 27 Wed May | 102.21 | 101.65 | 99.63 |
| 26 Tue May | 99.98 | 101.54 | 99.52 |
| 22 Fri May | 99.19 | 101.39 | 99.5 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 94.19 and 100 EMA is at 94.99
| Date | Closing Price | 100 SMA | 100 EMA |
| 01 Mon Jun | 94.92 | 94.19 | 94.99 |
| 29 Fri May | 99.56 | 94.07 | 94.99 |
| 28 Thu May | 100.41 | 93.89 | 94.9 |
| 27 Wed May | 102.21 | 93.73 | 94.79 |
| 26 Tue May | 99.98 | 93.58 | 94.64 |
| 22 Fri May | 99.19 | 93.46 | 94.53 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 84.58 and 200 EMA is at 85.29
| Date | Closing Price | 200 SMA | 200 EMA |
| 01 Mon Jun | 94.92 | 84.58 | 85.29 |
| 29 Fri May | 99.56 | 84.39 | 85.19 |
| 28 Thu May | 100.41 | 84.17 | 85.04 |
| 27 Wed May | 102.21 | 83.95 | 84.88 |
| 26 Tue May | 99.98 | 83.71 | 84.7 |
| 22 Fri May | 99.19 | 83.48 | 84.55 |
Vertex Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 7.63% more returns!
Staar Surgical has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Staar Surgical, about 11.93% more returns!
Ptc Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 17.79% more returns!
Protagonist Therapeutics has performed better than Pacira Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Phibro Animal in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Nektar Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Masimo Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Masimo Corporation, about 4.33% more returns!
Protagonist Therapeutics has performed better than Adma Biologics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Assertio Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 10.05% more returns!
Atara Biotherapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 120.29% more returns!
Protagonist Therapeutics has performed better than Cue Biopharma in short term. Holding Protagonist Therapeutics could be a better choice for now!
Dbv Technologies has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Dbv Technologies, about 0.78% more returns!
Fulgent Genetics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 25.73% more returns!
Integra Lifesciences has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Integra Lifesciences, about 22.85% more returns!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Protagonist Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term and the sell signal is strong.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Protagonist Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 99.39 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
